1.1(top 50%)
impact factor
67.4K(top 0.1%)
papers
1.7M(top 1%)
citations
379(top 1%)
h-index
1.3(top 50%)
impact factor
76.5K
all documents
1.7M
doc citations
604(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest19929,341
2Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based ApproachChest20105,657
3Prevention of Venous ThromboembolismChest20044,623
4Revisions in the International System for Staging Lung CancerChest19974,397
5Antithrombotic Therapy for VTE DiseaseChest20164,060
6A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial FibrillationChest20103,810
7Prevention of Venous ThromboembolismChest20083,752
8Antithrombotic Therapy for VTE DiseaseChest20123,745
9The APACHE III Prognostic SystemChest19913,488
10Prospective Trial of Supranormal Values of Survivors as Therapeutic Goals in High-Risk Surgical PatientsChest19882,298
11Prevention of Venous ThromboembolismChest20012,222
12International Classification of Sleep Disorders-Third EditionChest20142,148
13Relevance of Lung Ultrasound in the Diagnosis of Acute Respiratory Failure*: The BLUE ProtocolChest20082,122
14Elective Percutaneous Dilatational TracheostomyChest19851,960
15Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic ShockChest20091,941
16Pharmacology and Management of the Vitamin K AntagonistsChest20081,926
17C-Reactive Protein Levels Correlate With Mortality and Organ Failure in Critically Ill PatientsaChest20031,916
18The APACHE III Prognostic SystemChest19921,896
19Antithrombotic Therapy for Venous Thromboembolic DiseaseChest20081,860
20Prevention of VTE in Nonorthopedic Surgical PatientsChest20121,819
21Prevention of VTE in Nonsurgical PatientsChest20121,780
22Inadequate Antimicrobial Treatment of InfectionsChest19991,740
23Prevention of VTE in Orthopedic Surgery PatientsChest20121,723
24Proinflammatory CytokinesChest20001,692
25Blood Lactate Levels Are Superior to Oxygen-Derived Variables in Predicting Outcome in Human Septic ShockChest19911,664
26The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU SettingChest20001,641
27A New International Staging System for Lung CancerChest19861,494
28Mortality and Apnea Index in Obstructive Sleep ApneaChest19881,471
29Perioperative Management of Antithrombotic TherapyChest20121,461
30Executive SummaryChest20121,452
31VTE, Thrombophilia, Antithrombotic Therapy, and PregnancyChest20121,418
32Predicting Fluid Responsiveness in ICU PatientsChest20021,368
33Does Central Venous Pressure Predict Fluid Responsiveness?*: A Systematic Review of the Literature and the Tale of Seven MaresChest20081,348
34Regional Lymph Node Classification for Lung Cancer StagingChest19971,342
35Evaluation of Clinical Methods for Rating DyspneaChest19881,337
36Oral Anticoagulant TherapyChest20121,323
37Anti-Inflammatory CytokinesChest20001,320
38Effect of Failed Extubation on the Outcome of Mechanical VentilationChest19971,303
39Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and SafetyChest20011,275
40The Impact of Critical Illness on Perceived Health-Related Quality of Life During ICU Treatment, Hospital Stay, and After Hospital DischargeChest20081,260
41Antithrombotic Therapy in Neonates and ChildrenChest20121,229
42Methods for Staging Non-small Cell Lung CancerChest20131,218
43Antithrombotic Therapy for Venous Thromboembolic DiseaseChest20041,216
44High-Frequency Oscillatory Ventilation in AdultsChest20041,201
45The Measurement of DyspneaChest19841,192
46Grading Strength of Recommendations and Quality of Evidence in Clinical GuidelinesChest20061,146
47Pulmonary RehabilitationChest20071,145
48Comparison of the Sp o 2 /F io 2 Ratio and the Pa o 2 /F io 2 Ratio in Patients With Acute Lung Injury or ARDSChest20071,140
49Management of Spontaneous PneumothoraxChest20011,119
50Treatment of Stage I and II Non-small Cell Lung CancerChest20131,117